A NOVEL TELOMERASE-SPECIFIC ONCOLYTIC VIROTHERAPY TARGETING GASTRIC CANCER STEM CELLS

被引：0
|
作者：
Yano, Shuya [1 ]
Hashimoto, Yuuri [1 ,2 ]
Kojima, Toru [1 ]
Kuroda, Shinji [1 ]
Tazawa, Hiroshi [1 ]
Uno, Futoshi [1 ]
Kagawa, Shunsuke [1 ]
Urata, Yasuo [2 ]
Tanaka, Noriaki [1 ]
Fujiwara, Toshiyoshi [1 ,3 ]
机构：
[1] Okayama Univ, Grad Sch, Dept Surg, Okayama 7008558, Japan
[2] Oncolys BioPharma Inc, Minato Ku, Tokyo 1060032, Japan
[3] Okayama Univ Hosp, Ctr Gene & Cell Therapy, Okayama 7008558, Japan
来源：
JOURNAL OF GENE MEDICINE | 2009年 / 11卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1154 / 1154
页数：1
相关论文
共 50 条
  • [21] Preclinical evaluation of telomerase-specific oncolytic virotherapy for human bone and soft tissue sarcomas
    Sasaki, Tsuyoshi
    Tazawa, Hiroshi
    Hasei, Jo
    Kunisada, Toshiyuki
    Yoshida, Aki
    Morimoto, Yuki
    Urata, Yasuo
    Nouso, Kazuhiro
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2011, 71
  • [22] Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy
    Tazawa, Hiroshi
    Hasei, Joe
    Yano, Shuya
    Kagawa, Shunsuke
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCERS, 2020, 12 (02)
  • [23] Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas
    Sasaki, Tsuyoshi
    Tazawa, Hiroshi
    Hasei, Jo
    Kunisada, Toshiyuki
    Yoshida, Aki
    Hashimoto, Yuuri
    Yano, Shuya
    Yoshida, Ryosuke
    Uno, Futoshi
    Kagawa, Shunsuke
    Morimoto, Yuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CLINICAL CANCER RESEARCH, 2011, 17 (07) : 1828 - 1838
  • [24] Establishment of radiation-resistant stem-like esophageal cancer cells and apoptotic gene targeting by telomerase-specific oncolytic adenovirus
    Zhang, X.
    Komaki, R.
    Wang, L.
    Fang, B.
    Chang, J. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S38 - S38
  • [25] Telomerase-specific oncolytic adenovirus expressing TRAIL suppresses peritoneal dissemination of gastric cancer
    Zhou, W.
    Dai, S.
    Zhu, H.
    Song, Z.
    Cai, Y.
    Lee, J. B.
    Li, Z.
    Hu, X.
    Fang, B.
    He, C.
    Huang, X.
    GENE THERAPY, 2017, 24 (04) : 199 - 207
  • [26] Telomerase-specific virotherapy in an animal model of human head and neck cancer
    Nakajima, Oumi
    Matsunaga, Atsuko
    Ichimaru, Daiju
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    Kawakami, Koji
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (01) : 171 - 177
  • [27] Telomerase-specific oncolytic virotherapy promotes therapeuticefficacy of PD-1 blockade in murine osteosarcoma
    Mochizuki, Yusuke
    Tazawa, Hiroshi
    Demiya, Koji
    Komatsubara, Tadashi
    Sugiu, Kazuhisa
    Hasei, Joe
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2018, 78 (13)
  • [28] A Novel Antiangiogenic Effect for Telomerase-Specific Virotherapy through Host Immune System
    Fujiwara, Toshiyoshi
    Ikeda, Yoshihiro
    Kojima, Toru
    Kuroda, Shinji
    Endo, Yoshikatsu
    Uno, Futoshi
    Kagawa, Shunsuke
    Watanabe, Yuichi
    Hashimoto, Yuuri
    Urata, Yasuo
    Tanaka, Noriaki
    MOLECULAR THERAPY, 2009, 17 : S234 - S234
  • [29] Telomerase-specific virotherapy for human squamous cell carcinoma
    Fujiwara, Toshiyoshi
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (03) : 321 - 329
  • [30] Targeting the untargetable: Oncolytic virotherapy for the cancer stem cell
    Liu, Ta-Chiang
    Kirn, David
    MOLECULAR THERAPY, 2007, 15 (12) : 2060 - 2061
12345